作者: Paul Tardi , Lawrence Mayer , David Bermudes
DOI:
关键词: Liposome 、 Cetuximab 、 Epidermal growth factor receptor 、 Therapeutic effect 、 Bevacizumab 、 Camptothecin 、 Pharmacology 、 Growth factor 、 Chemistry 、 Cancer
摘要: Compositions which comprise a liposomal water-soluble camptothecin and optionally fluoropyrimidine in combination with vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal receptor (EGFR) bevacizumab are useful achieving enhanced therapeutic effects for the treatment of cancer.